Testosterone Supplements: Overcoming Current Misconceptions
About one fifth of patients with symptomatic testosterone deficiency receive treatment, partly because of misconceptions about the risks for therapy.
Source: medscape.com
Stay updated with breaking news from Odular Hyperplasia. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
About one fifth of patients with symptomatic testosterone deficiency receive treatment, partly because of misconceptions about the risks for therapy.
For men with hypogonadism and low prostate cancer risk, TRT didn't increase the risk for prostate adverse events, said a new analysis likely to inform decision-making.
A large randomized controlled trial found that testosterone replacement therapy did not increase the risk for prostate cancer in middle-aged and older men with hypogonadism.